TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts7577
Avg. Estimate-0.17-0.17-0.59-0.62
Low Estimate-0.19-0.18-0.61-0.7
High Estimate-0.13-0.16-0.55-0.56
Year Ago EPS-0.1-0.11-0.37-0.59
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts7377
Avg. Estimate5M5.02M16.04M52.36M
Low Estimate3.7M4.3M14.91M35.1M
High Estimate9.8M5.95M20.7M81.2M
Year Ago Sales4.12M3.77M16.78M16.04M
Sales Growth (year/est)21.20%33.10%-4.40%226.40%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.09-0.1-0.12-0.21
EPS Actual-0.1-0.11-0.15-0.16
Difference-0.01-0.01-0.030.05
Surprise %-11.10%-10.00%-25.00%23.80%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.17-0.17-0.59-0.62
7 Days Ago-0.17-0.17-0.59-0.57
30 Days Ago-0.17-0.17-0.59-0.57
60 Days Ago-0.17-0.15-0.59-0.42
90 Days Ago-0.17-0.13-0.59-0.32
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTXMDIndustrySectorS&P 500
Current Qtr.-70.00%N/AN/A0.03
Next Qtr.-54.50%N/AN/A0.04
Current Year-59.50%N/AN/A0.07
Next Year-5.10%N/AN/A0.10
Next 5 Years (per annum)15.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A